SET:AMARC

Asia Medical and Agricultural Laboratory and Research Center Public Company Limited · SET · Industrials · THB · FY for 2025

Figures on this page computed 2026-11-08 12:25 UTC

Last close

n/aTHB

Market data

  • 7.2xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    THB
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    THB
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 32.3%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    THB
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 32.4%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    THB
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.03Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    THB
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    THB
    • computed

Five bars, one line

lens 7 of 9
1.77x
4.26x
8.41x
0.23x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales1.77x

    Its own average over 8 years, 276.9M.

  • Profit4.26x

    Its own average over 8 years, 37.2M.

  • Free cash flow8.41x

    Its own average over 8 years, 18.9M.

  • Debt0.23x

    Its own average over 8 years, 89.6M.

  • Pricen/a

    Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 8.41 times.

Sales is 1.77 times its own 8-year average; Profit is 4.26 times its own 8-year average; Free cash flow is 8.41 times its own 8-year average; Debt is 0.23 times its own 8-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 8-year average1.77
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    THB
  • Profit against its own 8-year average4.26
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    THB
  • Free cash flow against its own 8-year average8.41
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    THB
  • Debt against its own 8-year average0.23
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    THB
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    THB

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.